EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Refining Stratification in Premenopausal Node-Positive HR+/HER2− Breast Cancer With a Novel AI-Based Test

Jailan Elayoubi, Cerise Tang, Kathryn J Ruddy, Khalil Choucair, Kevin Kalinsky, Katarzyna Pogoda, Francisco J Esteva, Jad M Abdelsattar, Virginia F Borges, Ken Zeng, Joseph Cappadona, Bartosz Machura und 3 weitere

Clinical Breast Cancer · 2026-08 · 26 (8) · 14-20

DOI: 10.1016/j.clbc.2026.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2026-08. Verfasst von Jailan Elayoubi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Artificial Intelligence. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Institute NSW, BC Cancer Agency, Health and Care Research Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm Recurrence, LocalArtificial IntelligenceHumansFemalePremenopauseErb-b2 Receptor Tyrosine KinasesAdultMiddle AgedPrognosisRisk AssessmentReceptors, EstrogenReceptors, ProgesteroneBiomarkers, Tumor

Stichwörter der Autor:innen

Artificial intelligenceHistopathologyNode-positive diseasePremenopausal womenPrognostic biomarker

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanReceptors, EstrogenReceptors, ProgesteroneBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI.
  • Ataraxis AI, New York, NY.
  • Department of Oncology, Mayo Clinic, Rochester, MN.
  • Winship Cancer Institute of Emory University, Atlanta, GA.
  • Department of Breast Cancer and Reconstructive Surgery, National Research Institute of Oncology in Warsaw, Warsaw, Poland.
  • Division of Hematology/Oncology, Northwell Health Cancer Institute, Lenox Hill Hospital, New York, NY.

Förderung

  • Cancer Institute NSW
  • BC Cancer Agency
  • Health and Care Research Wales
  • National Breast Cancer Foundation
  • Ontario Institute for Cancer Research
  • Cancer Research UK
  • National Health and Medical Research Council

Zitieren

APA

Elayoubi, J., Tang, C., Ruddy, K. J., Choucair, K., Kalinsky, K., Pogoda, K., Esteva, F. J., Abdelsattar, J. M., Borges, V. F., Zeng, K., Cappadona, J., Machura, B., Biswas, D., Geras, K. J., & Witowski, J. (2026). Refining Stratification in Premenopausal Node-Positive HR+/HER2− Breast Cancer With a Novel AI-Based Test. Clinical Breast Cancer, 26(8), 14-20. https://doi.org/10.1016/j.clbc.2026.06.001

Vancouver

Elayoubi J, Tang C, Ruddy KJ, Choucair K, Kalinsky K, Pogoda K, et al. Refining Stratification in Premenopausal Node-Positive HR+/HER2− Breast Cancer With a Novel AI-Based Test. Clinical Breast Cancer. 2026;26(8):14-20. doi:10.1016/j.clbc.2026.06.001

BibTeX
@article{Elayoubi2026,
  author = {Elayoubi, Jailan and Tang, Cerise and Ruddy, Kathryn J and Choucair, Khalil and Kalinsky, Kevin and Pogoda, Katarzyna and Esteva, Francisco J and Abdelsattar, Jad M and Borges, Virginia F and Zeng, Ken and Cappadona, Joseph and Machura, Bartosz and Biswas, Dhruva and Geras, Krzysztof J and Witowski, Jan},
  title = {Refining Stratification in Premenopausal Node-Positive HR+/HER2− Breast Cancer With a Novel AI-Based Test},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {8},
  pages = {14--20},
  doi = {10.1016/j.clbc.2026.06.001}
}
Kostenlos starten →